372 results for "Mystical Experience"
Dispositional Hypo-egoicism
Oxford Handbooks Online – October 05, 2016
Summary
What if a less self-centered mindset could unlock greater well-being and richer connections? Research reveals a disposition where individuals naturally minimize self-preoccupation, showing enhanced present-moment awareness and less egocentric thinking. These individuals balance personal interests with others' needs, display emotional equanimity, and are less concerned with external evaluation. They exhibit an agreeable, attentive, and caring interpersonal style, often experiencing profound states like flow, awe, and compassion. This disposition fosters a harmonious life.
Abstract
This chapter examines the cognitive, motivational, emotional, and interpersonal characteristics that distinguish hypo-egoic from egoic individuals ...
Future directions in meditation research: Recommendations for expanding the field of contemplative science
PLoS ONE – November 07, 2018
Summary
A compelling finding reveals the majority of 1120 meditators surveyed report extraordinary experiences, expanding the *field* of *meditation* research beyond traditional clinical effectiveness. While *Mindfulness and Compassion Interventions* have focused on *Behavioral Health*, new avenues explore deeper aspects of *Contemplation* and their implications for *medicine*. This rigorous *data science* approach acknowledges experiences often overlooked, providing critical insights for *mental health* challenges, particularly relevant post-*COVID-19*. Future studies demand careful *engineering ethics* to investigate these phenomena.
Abstract
The science of meditation has grown tremendously in the last two decades. Most studies have focused on evaluating the clinical effectiveness of min...
How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence
Anesthesia & Analgesia – February 17, 2021
Summary
Michael Pollan's 480-page "How to Change Your Mind" compellingly argues that psychedelics, particularly psilocybin, could revolutionize mental health. Named one of Time's top 100 influential people, Pollan explores their profound impact on consciousness, environmentalism, and counterculture. The book delves into the psychology and sociology of these substances, suggesting drug studies offer a unique "reboot" for conditions where conventional treatments fail, moving beyond traditional psychoanalysis. This engaging work encourages a cautious re-evaluation of psychedelics' therapeutic potential.
Abstract
It is tough to write about psychedelics without a few gratuitous puns. Regardless, Michael Pollan’s “How to Change Your Mind” is definitely “mind e...
Should addiction researchers be interested in psychedelic science?
Drug and Alcohol Review – April 10, 2017
Summary
Psychedelics are revolutionizing addiction psychology. In an open-label drug study, 80% of 15 people treated with psilocybin for tobacco addiction remained abstinent at six months, far exceeding standard pharmacotherapies. A survey of 358 individuals reported 74% abstained for over two years. MDMA, a unique synthetic compound, also shows promise for trauma, with 86% of PTSD patients in an RCT no longer meeting criteria. These findings highlight significant neurotransmitter receptor influence on behavior, offering new hope for complex addiction and psychological conditions.
Abstract
As recently noted by Strauss, Bright and Williams 1, while much of the Western world has been experiencing a renaissance in research into ‘psychede...
Messiah Drift and the Phenomenology of Psilocybin: Cross-Kingdom Neurotransmitter Interception and Clinical Integration
Zenodo (CERN European Organization for Nuclear Research) – December 25, 2025
Summary
Psilocybin's profound effects may stem from a surprising **biology** of cross-kingdom **communication**. A compelling **neuroscience** hypothesis posits psilocybin as an intercellular signaling molecule from mycelial networks, activating mammalian 5-HT2A receptors through evolutionary conservation. This **crosstalk** explains the **phenomenological coherence** of psychedelic experiences as self-generated under altered constraints, a key insight for **Cognitive science**. For clinical **Psychedelics and Drug Studies**, a practical five-step anchoring protocol helps facilitators manage archetypal responses, addressing integration challenges with a dual-drift model in **Psychology**.
Abstract
Abstract This paper addresses two critical gaps as legal psilocybin mental health services expand: practical clinical protocols for integration cha...
What can we learn from the history of research on psychedelic drugs in the addictions?
Addiction – August 12, 2021
Summary
Early **psychedelic** **drug** **studies** in the 1950s showed promise for **addiction** treatment. One approach using LSD for alcohol dependence reported 50% of 24 patients greatly or moderately improved, describing profound psychological experiences. However, later, more controlled **drug** trials and a meta-analysis found that while initial benefits occurred up to six months, they did not persist at 12 months. **Psychiatry** and **medicine** must proceed cautiously with these powerful **compounds**, ensuring rigorous clinical trials define their role in **addiction** **psychology** to avoid past mistakes in their therapeutic use.
Abstract
The history of research on the use of psychedelic drugs to treat alcohol dependence in the 1950s and 1960s suggests the need for caution in their p...
Dose-response relationships of LSD-induced subjective experiences in humans
OpenAlex – November 07, 2022
Summary
Lysergic acid diethylamide (LSD), a potent hallucinogen, profoundly alters consciousness, with effects largely plateauing around 100 μg. A meta-analysis in Psychology, utilizing subjective rating scales, reveals strong changes in perception and ego-dissolution. Crucially, minimal effects on Anxiety were observed. These findings from Psychedelics and Drug Studies provide vital dose-response data for clinical psychology, informing how this chemical synthesis product impacts the mind. Understanding these biochemical effects on consciousness offers a foundation for further research, even for social and developmental psychology.
Abstract
Abstract Lysergic acid diethylamide (LSD) is a potent classic serotonergic psychedelic, which facilitates a variety of altered states of consciousn...
Use of Ayahuasca among Rubber Tappers of the Upper Juruá
Fieldwork in Religion – November 27, 2008
Summary
Ayahuasca has become a powerful symbol of resistance among rubber tappers in the Alto Juruá region, where 70% reported its use as part of their cultural identity. This practice blends Indigenous and non-Indigenous traditions, with many rubber tappers becoming renowned healers. Since the 1980s, ayahuasca rituals have intertwined with political struggles against exploitative bosses, fostering a unique synthesis that includes elements from Santo Daime's religious doctrine. This dynamic reflects broader sociocultural changes and highlights the resilience of local communities in the Brazilian Amazon.
Abstract
The article is the fruit of co-authorship between an anthropologist with long research experience in the area of the Extractivist Reserve of the Al...
Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study Participation: Comparaison des effets antidépresseurs de la psychothérapie assistée par la psilocybine (PAP) chez les personnes non médicamentées à la sélection initiale et les personnes ayant arrêté les médicaments pour participer à l’étude
The Canadian Journal of Psychiatry – March 25, 2025
Summary
Patients experiencing major depressive episodes achieved comparable relief from depression, anxiety, and suicidal ideation, whether they tapered off antidepressants (n=18) or were unmedicated (n=9) when receiving psilocybin-assisted psychotherapy. This medicine, a psychedelic alkaloid influencing neurotransmitter receptors, offers a novel approach in psychiatry. A randomized controlled trial involving 27 participants showed a single 25mg psilocybin dose provided clinically significant benefits over two months, impacting clinical psychology and advancing drug studies.
Abstract
Objective: To compare changes in depression, anxiety, and suicidality symptoms after a single 25 mg oral dose of psilocybin between treatment-resis...
Disentangling the acute subjective effects of classic psychedelics from their enduring therapeutic properties.
Psychopharmacology – May 14, 2024
Summary
Groundbreaking neuropsychiatry research reveals that psilocybin and other classic psychedelics may not need to produce intense psychological experiences to be therapeutic. While traditional treatments rely on profound mental journeys, new evidence suggests these compounds can treat depression and addiction by directly rewiring brain circuits through 5-HT2A receptor activation, even without hallucinogenic effects.
Abstract
Recent research with classic psychedelics suggests significant therapeutic potential, particularly for neuropsychiatric disorders. A mediating infl...
Psychedelics, Meaningfulness, and the "Proper Scope" of Medicine: Continuing the Conversation.
Cambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees – June 27, 2023
Summary
Emerging research reveals that psychedelics' therapeutic benefits may be deeply linked to their consciousness-altering effects. While these substances show promise in treating depression and addiction, debate continues over whether their healing potential requires the profound subjective experiences they typically produce. The key question: Can we separate the medical benefits from the mystical journey?
Abstract
Psychedelics such as psilocybin reliably produce significantly altered states of consciousness with a variety of subjectively experienced effects. ...
Modern Clinical Research on LSD
Neuropsychopharmacology – April 27, 2017
Summary
LSD significantly enhances emotional experiences, fostering feelings of closeness and empathy while impairing recognition of sad and fearful faces. In a review of six studies involving 250 participants, LSD's effects included increased brain connectivity and altered perceptions, linked to the 5-HT2A receptor. Notably, patients with anxiety experienced reduced symptoms for up to two months after treatment. Additionally, LSD elevated levels of cortisol and oxytocin, suggesting its potential in therapeutic settings. Overall, these findings highlight LSD's promising role in neuroscience and mental health treatment.
Abstract
All modern clinical studies using the classic hallucinogen lysergic acid diethylamide (LSD) in healthy subjects or patients in the last 25 years ar...